Efocipegtrutide (HM15211)

Efocipegtrutide · Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Efocipegtrutide (HM15211), covering 2024-05-17 to 2025-01-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD [Phase 1]